Physician profile
Karthik Reddy
NPI 1881755429
$1,976.31
in general payments reported to CMS, 2019-2025
18 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $96.65 · 2021: $207 · 2022: $436 · 2023: $18.42 · 2024: $313 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659 · Travel and Lodging: $366 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.28 |
| Travel and Lodging | $365.58 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $908.20 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Shockwave Medical, INC | $137.25 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2021 | |
| Novo Nordisk INC | $121.83 | 2024 | |
| Lantheus Medical Imaging, INC. | $98.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $92.36 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $88.06 | 2020-2022 | |
| Henry Schein, INC. | $72.34 | 2024 | |
| Philips North America LLC | $66.57 | 2024-2025 | Coronary Other, (Bq9) Coronary Ivus, Omniwire |
| Eyevance Pharmaceuticals LLC | $63.76 | 2022 | |
| Pfizer INC. | $38.52 | 2019-2021 | |
| Medtronic Vascular, INC. | $32.80 | 2019-2020 | |
| Terumo Medical Corporation | $32.59 | 2023-2025 | Heartrail, Metacross Otw |
| Novartis Pharmaceuticals Corporation | $24.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $18.62 | 2019 | |
| Neurocrine Biosciences, INC. | $18.54 | 2019 | |
| Organogenesis INC. | $16.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karthik Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.